ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 28 filers reported holding ELEVATION ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $273,971 | -56.3% | 288,390 | -48.0% | 0.05% | -74.5% |
Q3 2022 | $627,000 | -19.3% | 555,000 | 0.0% | 0.19% | -43.0% |
Q2 2022 | $777,000 | -44.5% | 555,000 | 0.0% | 0.33% | -41.3% |
Q1 2022 | $1,399,000 | -58.1% | 555,000 | 0.0% | 0.56% | -64.1% |
Q4 2021 | $3,341,000 | – | 555,000 | – | 1.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 2,834,910 | $7,654,257 | 3.31% |
venBio Partners LLC | 2,434,255 | $6,572,489 | 2.84% |
Velan Capital Investment Management LP | 597,299 | $1,612,707 | 0.92% |
Exome Asset Management LLC | 369,322 | $997,170 | 0.87% |
Logos Global Management LP | 3,850,000 | $10,395,000 | 0.84% |
TANG CAPITAL MANAGEMENT LLC | 3,060,000 | $8,262,000 | 0.84% |
Palo Alto Investors LP | 1,800,106 | $4,860,286 | 0.56% |
Darwin Global Management, Ltd. | 1,916,290 | $4,809,888 | 0.56% |
Ghost Tree Capital, LLC | 600,000 | $1,620,000 | 0.51% |
Affinity Asset Advisors, LLC | 1,468,825 | $3,965,828 | 0.46% |